Postgrad LIVE! Study Fairs

Birmingham | Edinburgh | Liverpool | Sheffield | Southampton | Bristol

University of Liverpool Featured PhD Programmes
University of Kent Featured PhD Programmes
University College London Featured PhD Programmes
Engineering and Physical Sciences Research Council Featured PhD Programmes
University College London Featured PhD Programmes
"cell" AND "therapy"×
10 miles

cell therapy PhD Projects, Programs & Scholarships

We have 137 cell therapy PhD Projects, Programs & Scholarships

  • "cell" AND "therapy" ×
  • clear all
Order by 
Showing 1 to 10 of 137
  Gene and Cell Therapy For Muscular Dystrophy, Muscular Atrophy, Diabetes and Metabolic conditions
  Dr K Foster
Applications accepted all year round
Skeletal muscle development is a complex process and a number of regulatory factors for the different steps involved in stem cell activation and proliferation through to multinucleated, post-mitotic cells have been identified.
  Generation of high-performance cellular models for neurodegenerative diseases
  Dr Y Choo
Application Deadline: 15 December 2018
Fully-funded industrial PhD studentship in stem cell research for neurodegenerative disease. CONTRACT. Full time employee (Research Student) at Plasticell Ltd.
  MRC Precision Medicine DTP: Connecting Molecular Profiles to Phenotype: A Proteomic Resource for Assigning Cell Cycle and Senescent States
  Research Group: Institute of Cell Biology
  Dr T Ly, Dr A Lindqvist
Application Deadline: 7 January 2019
Background. Cellular heterogeneity is frequently found in solid tumours and is thought to contribute to resistance to cancer therapy.
  Hematopoietic Stem Cell Genetics: Using single cell biology and genetics to understand how hematopoietic stem cells normally sustain blood formation, and how this process is altered during ageing and when leukemia develops.
  Prof Claus Nerlov, Dr P Vyas
Application Deadline: 11 January 2019
Using single cell biology and genetics to understand how hematopoietic stem cells normally sustain blood formation, and how this process is altered during ageing and when leukemia develops.
  MRC DiMeN Doctoral Training Partnership: Harnessing T cells to target brain metastases
  Dr M Lorger, Dr R Salmond, Prof J Newton-Bishop
Application Deadline: 21 January 2019
An MRC-funded PhD student position is available to explore how T cells can be harnessed to enhance the efficacy of immune checkpoint inhibitors in melanoma brain metastases.
  Stem cell binding to the endothelium during extravasation
  Prof G Cossu, Prof N Tirelli
Applications accepted all year round
In a previous clinical trial carried out by the team (Cossu et al. 2015), HLA-matched, donor mesoangioblasts (pericyte-derived myogenic progenitors) were infused intra-arterially to patients with Duchenne muscular dystrophy.
  Wellcome Trust 4 year PhD Programme in Cell Therapies and Regenerative Medicine
Keywords. Kings, King's, KCL, biological sciences.  . The Wellcome Trust. ‘Cell Therapies and Regenerative Medicine'. Four-Year PhD Programme at King's College London.
  The effect of polysialyltransferase modulation on tumour cell migration
  Research Group: Institute of Cancer Therapeutics
  Dr S Shnyder, Dr R Falconer
Applications accepted all year round
One of the main reasons for failure of cancer therapy today is an inability to control tumour dissemination, with secondary tumour deposits the cause of morbidity.
  How to fix a broken heart - The next frontier: from cell to cage side treatment
  Dr D Connolly, Prof D Werling, Dr J Dudhia
Application Deadline: 10 February 2019
Dilated Cardiomyopathy (DCM) is a common and serious disease, which imposes a significant welfare burden in dogs. DCM is particularly well characterise in Dobermans where a 58.8% cumulative prevalence has been identified in European lines.
  Identifying the role of glycosaminoglycans and microglia in early pathology of mucopolysaccharide diseases
  Dr B BIgger, Dr R Holley, Prof S Flitsch
Applications accepted all year round
Mucopolysaccharidoses (MPS) are inherited metabolic disorders caused by the deficiency of specific lysosomal enzymes required for the catabolism of glycosaminoglycans (GAGs) where each MPS type lacks a specific enzyme resulting in the build-up of GAGs in all cells of the body.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2018
All rights reserved.